aspirin has been researched along with Diabetes Mellitus, Type 1 in 98 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| ", aspirin alone (330 mg 3 times daily) or in combination with dipyridamole (75 mg 3 times daily), was tested versus placebo in 475 patients with early diabetic retinopathy." | 9.06 | Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. The DAMAD Study Group. ( , 1989) |
| " Following a three week course of aspirin (330 mg)--dipyridamole (75 mg) taken three times daily there was significant reduction in exercise-induced albuminuria (expressed as the ratio of albumin excretion rate during exercise to that at rest before exercise) when compared to administration of placebo (P less than 0." | 9.06 | Reduction of exercise-induced albuminuria by aspirin-dipyridamole in patients with diabetes mellitus. ( Davies, JA; Hopper, AH; Tindall, H; Urquhart, S, 1987) |
| "The incidence of preeclampsia was similar in the 1254 women in the aspirin group and the 1249 women in the placebo group (aspirin, 18 percent; placebo, 20 percent; P=0." | 6.69 | Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. ( Caritis, S; Hauth, J; Klebanoff, M; Landon, M; Lindheimer, MD; Meis, P; Miodovnik, M; Paul, R; Sibai, B; Thom, E; Thurnau, G; VanDorsten, P, 1998) |
| "Type 1 diabetes mellitus was established by intraperitoneal injection of streptozotocin (65 mg/kg)." | 5.91 | Long-term aspirin administration suppresses inflammation in diabetic cystopathy. ( Du, H; Li, N; Liu, J; Qin, Y; Xu, F; Xu, Y; Zhang, J, 2023) |
| "Glucose concentrations within target, appropriate gestational weight gain, adequate lifestyle, and, if necessary, antihypertensive treatment and low-dose aspirin reduces the risk of pre-eclampsia, preterm delivery, and other adverse pregnancy and neonatal outcomes in pregnancies complicated by type 1 diabetes." | 5.41 | Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets. ( Battelino, T; Benhalima, K; Beunen, K; Buschur, E; Donovan, LE; Feig, DS; Kudva, YC; Levy, CJ; Mathiesen, ER; Mathieu, C; Murphy, HR; Painter, R; Polsky, S; Ringholm, L; Siegelaar, SE, 2023) |
| "We describe a patient with type 1 diabetes who had infarction of the muscles in her right thigh." | 5.30 | Enhanced platelet aggregation, high homocysteine level, and microvascular disease in diabetic muscle infarctions: implications for therapy. ( Levy, J; Ragatzki, P; Rajkumar, V; Sima, A, 1999) |
| "This was a prospective observation of pregnancy outcomes among 462 women with pregestational diabetes mellitus (White classes B-F) and singleton pregnancies who were enrolled in a multicenter trial to compare low-dose aspirin with placebo for preeclampsia prevention." | 5.09 | Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. ( Caritis, S; Dombrowski, M; Hauth, J; Klebanoff, M; Landon, M; Lindheimer, M; MacPherson, C; McNellis, D; Meis, P; Miodovnik, M; Paul, R; Roberts, J; Sibai, BM; Thurnau, G; VanDorsten, JP, 2000) |
| ", aspirin alone (330 mg 3 times daily) or in combination with dipyridamole (75 mg 3 times daily), was tested versus placebo in 475 patients with early diabetic retinopathy." | 5.06 | Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. The DAMAD Study Group. ( , 1989) |
| " Following a three week course of aspirin (330 mg)--dipyridamole (75 mg) taken three times daily there was significant reduction in exercise-induced albuminuria (expressed as the ratio of albumin excretion rate during exercise to that at rest before exercise) when compared to administration of placebo (P less than 0." | 5.06 | Reduction of exercise-induced albuminuria by aspirin-dipyridamole in patients with diabetes mellitus. ( Davies, JA; Hopper, AH; Tindall, H; Urquhart, S, 1987) |
| "Aspirin administration, reduced the protein expression of Mysm1, increased the protein expression of H2AK119-Ub and thereby reduced the Set7 protein expression in glomeruli isolated from diabetic animals and prevented renal fibrosis." | 3.88 | Novel reno-protective mechanism of Aspirin involves H2AK119 monoubiquitination and Set7 in preventing type 1 diabetic nephropathy. ( Gaikwad, AB; Goru, SK, 2018) |
| "Aspirin use for primary prevention in patients at high risk with diabetes mellitus (DM) is often recommended under the assumption that most patients with DM have coronary artery disease (CAD)." | 3.83 | Value of Coronary Computed Tomography Angiography in Tailoring Aspirin Therapy for Primary Prevention of Atherosclerotic Events in Patients at High Risk With Diabetes Mellitus. ( Bax, JJ; de Graaf, MA; Delgado, V; Dimitriu-Leen, AC; Jukema, JW; Kharagjitsingh, AV; Knuuti, J; Kroft, LJ; Scholte, AJ; van den Hoogen, IJ; van Rosendael, AR; Wolterbeek, R, 2016) |
| " This adherence was concerned particularly with co-medication in patients diagnosed with hypertension, aspirin prescription in elderly patients and the achievement of target lipid levels following the prescription of statins." | 3.79 | Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study. ( Hintersteiner, J; Johnson, J; Kamyar, MR; Kautzky, A; Kautzky-Willer, A; Lemmens-Gruber, R; Saukel, J; Stich, K, 2013) |
| "A total of 48 participants with type 1 diabetes and 48 healthy controls were randomised to receive aspirin 75 or 300 mg once-daily (OD) in an open-label crossover study." | 3.01 | A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control. ( Ajjan, RA; Grant, PJ; Hawkins, F; Kurdee, Z; Naseem, KM; Parker, WAE; Sagar, R; Storey, RF, 2021) |
| "Patients with type 1 diabetes form a less permeable fibrin network, which could contribute to their increased risk of cardiovascular disease (CVD)." | 2.77 | High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes. ( Adamson, U; Antovic, A; Jörneskog, G; Lins, PE; Mageed, K; Mobarrez, F; Tehrani, S; Wallén, HN, 2012) |
| "Preeclampsia is a severe pregnancy complication with high potential for adverse effects on maternal and fetal health during the perinatal period." | 2.72 | Family History of Hypertension, Cardiovascular Disease, or Diabetes and Risk of Developing Preeclampsia: A Systematic Review. ( Kay, VR; Smith, GN; Wedel, N, 2021) |
| "Aspirin sensitivity was defined as inhibition (i." | 2.71 | Aspirin sensitivity of platelet aggregation in diabetes mellitus. ( Albert, SG; Hasnain, BI; Joist, JH; Mooradian, AD; Ritter, DG, 2005) |
| "The incidence of preeclampsia was similar in the 1254 women in the aspirin group and the 1249 women in the placebo group (aspirin, 18 percent; placebo, 20 percent; P=0." | 2.69 | Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. ( Caritis, S; Hauth, J; Klebanoff, M; Landon, M; Lindheimer, MD; Meis, P; Miodovnik, M; Paul, R; Sibai, B; Thom, E; Thurnau, G; VanDorsten, P, 1998) |
| "Accommodative amplitudes in Early Treatment Diabetic Retinopathy Study patients were lower than normal accommodative amplitudes." | 2.68 | Accommodative amplitudes in the Early Treatment Diabetic Retinopathy Study. ( Benson, WE; Braun, CI; Chew, EY; Ferris, FL; Remaley, NA, 1995) |
| "Patients with asymptomatic internal carotid artery stenosis exceeding 60% reduction in diameter who are acceptable candidates for elective operation may be considered for CEA if the combined arteriographic and surgical complication rates are 3% or less." | 2.68 | An analysis of perioperative surgical mortality and morbidity in the asymptomatic carotid atherosclerosis study. ACAS Investigators. Asymptomatic Carotid Atherosclerosis Study. ( Broderick, JP; Cohen, SN; Dempsey, RJ; Ernst, CB; Hosking, JD; Moore, WS; Robertson, JT; Toole, JF; Young, B, 1996) |
| "In the IDDM patients, baseline LDF (median: 27 (19-35); interquartile range) vs." | 2.67 | Peripheral macro- and microcirculation in short-term insulin-dependent diabetes mellitus: the role of prostaglandins in early haemodynamic changes. ( Bouhouch, E; Houben, AJ; Nieuwenhuijzen Kruseman, AC; Schaper, NC; Slaaf, DW, 1993) |
| "Aspirin resistance has been often considered a guilty actor, although many mechanisms have been mistaken for true aspirin resistance, such as patient poor compliance, inadequate dosing, drug interactions, and high-platelet turnover." | 2.58 | Aspirin in primary prevention for patients with diabetes: Still a matter of debate. ( Bonaventura, A; Liberale, L; Montecucco, F, 2018) |
| "Careful counseling of women with diabetic nephropathy before pregnancy with estimation of the risk for the mother and fetus is important." | 2.48 | Obstetric nephrology: pregnancy in women with diabetic nephropathy--the role of antihypertensive treatment. ( Clausen, P; Damm, P; Feldt-Rasmussen, B; Mathiesen, ER; Ringholm, L, 2012) |
| "Insulin-dependent diabetes mellitus (IDDM) and systemic lupus erythematosus (SLE) are two common autoimmune disorders that affect women of childbearing age." | 2.39 | Nutritional consequences of chronic maternal conditions during pregnancy and lactation: lupus and diabetes. ( Ferris, AM; Reece, EA, 1994) |
| "Type 1 diabetes mellitus was established by intraperitoneal injection of streptozotocin (65 mg/kg)." | 1.91 | Long-term aspirin administration suppresses inflammation in diabetic cystopathy. ( Du, H; Li, N; Liu, J; Qin, Y; Xu, F; Xu, Y; Zhang, J, 2023) |
| "Treatment of aspirin significantly prevented the progression of nephropathy and inhibited the augmented COX-2, NFkappaB (p65 levels), TNFalpha, and TGFbeta-smad expression." | 1.36 | Combination of aspirin with telmisartan suppresses the augmented TGFbeta/smad signaling during the development of streptozotocin-induced type I diabetic nephropathy. ( Gaikwad, AB; Mulay, SR; Tikoo, K, 2010) |
| " In this study, we investigated the effect of high-dose and long-term use of acetyl salicylic acid (ASA) on the streptozotocin-induced diabetic rats as a model of type I diabetes, with consideration on the structure and/or function of proteins." | 1.35 | Investigation of the mechanisms involved in the high-dose and long-term acetyl salicylic acid therapy of type I diabetic rats. ( Bathaie, SZ; Hassan, MZ; Jafarnejad, A; Nakhjavani, M, 2008) |
| "Aspirin resistance was not related to age, glycohemoglobin, total cholesterol, or a history of cardiovascular disease." | 1.33 | Comparison of aspirin resistance in type 1 versus type 2 diabetes mellitus. ( Aaronson, A; Abrahamson, M; Goldfine, AB; Mehta, SS; Silver, RJ, 2006) |
| " An independent endpoint review committee adjudicated all reported major adverse cardiovascular events, stent thromboses, and target-vessel revascularizations." | 1.33 | Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry. ( Berge, C; Deme, M; Gershlick, AH; Guagliumi, G; Guyon, P; Lotan, C; Schofer, J; Seth, A; Sousa, JE; Stoll, HP; Urban, P; Wijns, W, 2006) |
| "During follow-up 56 recurrences occurred, making a total of 110 episodes of vitreous haemorrhage in 79 eyes of 54 patients." | 1.32 | Does cardiovascular therapy affect the onset and recurrence of preretinal and vitreous haemorrhage in diabetic eye disease? ( Banerjee, S; Denniston, AK; Dodson, PM; Gibson, JM, 2004) |
| "We describe a patient with type 1 diabetes who had infarction of the muscles in her right thigh." | 1.30 | Enhanced platelet aggregation, high homocysteine level, and microvascular disease in diabetic muscle infarctions: implications for therapy. ( Levy, J; Ragatzki, P; Rajkumar, V; Sima, A, 1999) |
| "Aspirin treatment also reduced the slope of the aggregation curve and increased the lag time (the period between the addition of collagen and the start of irreversible aggregation) significantly more in control than in diabetic platelets." | 1.28 | Differential effect of aspirin on platelet aggregation in IDDM. ( Burke, V; Douglas, AJ; McCulloch, RK; Mori, TA; Vandongen, R, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (17.35) | 18.7374 |
| 1990's | 22 (22.45) | 18.2507 |
| 2000's | 36 (36.73) | 29.6817 |
| 2010's | 17 (17.35) | 24.3611 |
| 2020's | 6 (6.12) | 2.80 |
| Authors | Studies |
|---|---|
| Parker, WAE | 1 |
| Sagar, R | 1 |
| Kurdee, Z | 1 |
| Hawkins, F | 1 |
| Naseem, KM | 1 |
| Grant, PJ | 1 |
| Storey, RF | 1 |
| Ajjan, RA | 1 |
| Benhalima, K | 1 |
| Beunen, K | 1 |
| Siegelaar, SE | 1 |
| Painter, R | 1 |
| Murphy, HR | 1 |
| Feig, DS | 1 |
| Donovan, LE | 1 |
| Polsky, S | 1 |
| Buschur, E | 1 |
| Levy, CJ | 1 |
| Kudva, YC | 1 |
| Battelino, T | 1 |
| Ringholm, L | 2 |
| Mathiesen, ER | 2 |
| Mathieu, C | 2 |
| Du, H | 1 |
| Xu, F | 1 |
| Liu, J | 1 |
| Zhang, J | 1 |
| Qin, Y | 1 |
| Xu, Y | 1 |
| Li, N | 1 |
| Hameed, AB | 1 |
| Combs, CA | 1 |
| Kay, VR | 1 |
| Wedel, N | 1 |
| Smith, GN | 1 |
| Ju, L | 1 |
| McFadyen, JD | 1 |
| Al-Daher, S | 1 |
| Alwis, I | 1 |
| Chen, Y | 1 |
| Tønnesen, LL | 1 |
| Maiocchi, S | 1 |
| Coulter, B | 1 |
| Calkin, AC | 1 |
| Felner, EI | 1 |
| Cohen, N | 1 |
| Yuan, Y | 1 |
| Schoenwaelder, SM | 1 |
| Cooper, ME | 1 |
| Zhu, C | 1 |
| Jackson, SP | 1 |
| Goru, SK | 1 |
| Gaikwad, AB | 2 |
| Bonaventura, A | 1 |
| Liberale, L | 1 |
| Montecucco, F | 1 |
| Monif, GRG | 1 |
| Egan, AM | 1 |
| Brassill, MJ | 1 |
| Brosnan, E | 1 |
| Carmody, L | 1 |
| Clarke, H | 1 |
| Coogan Kelly, C | 1 |
| Culliney, L | 1 |
| Durkan, M | 1 |
| Fenlon, M | 1 |
| Ferry, P | 1 |
| Hanlon, G | 1 |
| Higgins, T | 1 |
| Hoashi, S | 1 |
| Khamis, A | 1 |
| Kinsley, B | 1 |
| Kinsley, T | 1 |
| Kirwan, B | 1 |
| Liew, A | 1 |
| McGurk, C | 1 |
| McHugh, C | 1 |
| Murphy, MS | 1 |
| Murphy, P | 1 |
| O'Halloran, D | 1 |
| O'Mahony, L | 1 |
| O'Sullivan, E | 1 |
| Nolan, M | 1 |
| Peter, M | 1 |
| Roberts, G | 1 |
| Smyth, A | 1 |
| Todd, M | 1 |
| Tuthill, A | 1 |
| Wan Mahmood, WA | 1 |
| Yousif, O | 1 |
| P Dunne, F | 1 |
| Kautzky-Willer, A | 1 |
| Stich, K | 1 |
| Hintersteiner, J | 1 |
| Kautzky, A | 1 |
| Kamyar, MR | 1 |
| Saukel, J | 1 |
| Johnson, J | 1 |
| Lemmens-Gruber, R | 1 |
| Zaccardi, F | 1 |
| Rizzi, A | 1 |
| Petrucci, G | 1 |
| Ciaffardini, F | 1 |
| Tanese, L | 1 |
| Pagliaccia, F | 1 |
| Cavalca, V | 1 |
| Ciminello, A | 1 |
| Habib, A | 1 |
| Squellerio, I | 1 |
| Rizzo, P | 1 |
| Tremoli, E | 1 |
| Rocca, B | 1 |
| Pitocco, D | 2 |
| Patrono, C | 1 |
| Wisinski, JA | 1 |
| Kimple, ME | 1 |
| Dimitriu-Leen, AC | 1 |
| Scholte, AJ | 1 |
| van Rosendael, AR | 1 |
| van den Hoogen, IJ | 1 |
| Kharagjitsingh, AV | 1 |
| Wolterbeek, R | 1 |
| Knuuti, J | 1 |
| Kroft, LJ | 1 |
| Delgado, V | 1 |
| Jukema, JW | 1 |
| de Graaf, MA | 1 |
| Bax, JJ | 1 |
| Chiva-Blanch, G | 1 |
| Suades, R | 1 |
| Padró, T | 1 |
| Vilahur, G | 1 |
| Peña, E | 1 |
| Ybarra, J | 1 |
| Pou, JM | 1 |
| Badimon, L | 1 |
| Belch, J | 1 |
| MacCuish, A | 1 |
| Campbell, I | 1 |
| Cobbe, S | 1 |
| Taylor, R | 1 |
| Prescott, R | 1 |
| Lee, R | 1 |
| Bancroft, J | 1 |
| MacEwan, S | 1 |
| Shepherd, J | 1 |
| Macfarlane, P | 1 |
| Morris, A | 1 |
| Jung, R | 1 |
| Kelly, C | 1 |
| Connacher, A | 1 |
| Peden, N | 1 |
| Jamieson, A | 1 |
| Matthews, D | 1 |
| Leese, G | 1 |
| McKnight, J | 1 |
| O'Brien, I | 1 |
| Semple, C | 1 |
| Petrie, J | 1 |
| Gordon, D | 1 |
| Pringle, S | 1 |
| MacWalter, R | 1 |
| Zaslavskaia, RM | 2 |
| Tulemisov, EU | 2 |
| Pulcinelli, FM | 1 |
| Biasucci, LM | 1 |
| Riondino, S | 1 |
| Giubilato, S | 1 |
| Leo, A | 1 |
| Di Renzo, L | 1 |
| Trifirò, E | 1 |
| Mattiello, T | 1 |
| Liuzzo, G | 1 |
| Ghirlanda, G | 2 |
| Crea, F | 1 |
| Jackson, G | 1 |
| Roffi, M | 1 |
| Eberli, FR | 1 |
| De La Cruz, JP | 4 |
| Del Río, S | 1 |
| Arrebola, MM | 3 |
| López-Villodres, JA | 1 |
| Jebrouni, N | 1 |
| González-Correa, JA | 3 |
| LaMarr, B | 1 |
| Valdez, C | 1 |
| Driscoll, K | 1 |
| Ryan, M | 1 |
| Mulay, SR | 1 |
| Tikoo, K | 1 |
| Ghannoum, JE | 1 |
| Odingo, NA | 1 |
| Provost, N | 1 |
| Tehrani, S | 1 |
| Antovic, A | 1 |
| Mobarrez, F | 1 |
| Mageed, K | 1 |
| Lins, PE | 1 |
| Adamson, U | 1 |
| Wallén, HN | 1 |
| Jörneskog, G | 1 |
| Grove, EL | 1 |
| Gregersen, S | 1 |
| Feldt-Rasmussen, B | 1 |
| Clausen, P | 1 |
| Damm, P | 1 |
| Serebruany, VL | 1 |
| Dinicolantonio, JJ | 1 |
| Can, MM | 1 |
| Goto, S | 1 |
| Bell, DS | 1 |
| Bennett, KE | 1 |
| Williams, D | 1 |
| Feely, J | 1 |
| Gysemans, C | 1 |
| Stoffels, K | 1 |
| Giulietti, A | 1 |
| Overbergh, L | 1 |
| Waer, M | 1 |
| Lannoo, M | 1 |
| Feige, U | 1 |
| Fong, DS | 1 |
| Aiello, L | 1 |
| Gardner, TW | 1 |
| King, GL | 1 |
| Blankenship, G | 1 |
| Cavallerano, JD | 1 |
| Ferris, FL | 3 |
| Klein, R | 2 |
| Banerjee, S | 1 |
| Denniston, AK | 1 |
| Gibson, JM | 1 |
| Dodson, PM | 1 |
| Claudi, T | 1 |
| Cooper, JG | 1 |
| Hausken, MF | 1 |
| Michaelsen, T | 1 |
| Harboe, K | 1 |
| Ingskog, W | 1 |
| ØStrem, A | 1 |
| Löbner, K | 1 |
| Füchtenbusch, M | 1 |
| Ragoobirsingh, D | 1 |
| Morrison, EY | 1 |
| Reid, HL | 1 |
| Wilson, AM | 1 |
| Boyle, AJ | 1 |
| Fox, P | 1 |
| Soedamah-Muthu, SS | 1 |
| Stehouwer, CD | 1 |
| Albert, SG | 1 |
| Hasnain, BI | 1 |
| Ritter, DG | 1 |
| Joist, JH | 1 |
| Mooradian, AD | 1 |
| Charpentier, G | 1 |
| Puel, J | 1 |
| Steg, PG | 1 |
| Brogan, GX | 1 |
| Peterson, ED | 1 |
| Mulgund, J | 1 |
| Bhatt, DL | 1 |
| Ohman, EM | 1 |
| Gibler, WB | 1 |
| Pollack, CV | 1 |
| Farkouh, ME | 1 |
| Roe, MT | 1 |
| Watala, C | 1 |
| Boncler, M | 1 |
| Gresner, P | 1 |
| Mehta, SS | 1 |
| Silver, RJ | 1 |
| Aaronson, A | 1 |
| Abrahamson, M | 1 |
| Goldfine, AB | 1 |
| Urban, P | 1 |
| Gershlick, AH | 1 |
| Guagliumi, G | 1 |
| Guyon, P | 1 |
| Lotan, C | 1 |
| Schofer, J | 1 |
| Seth, A | 1 |
| Sousa, JE | 1 |
| Wijns, W | 1 |
| Berge, C | 1 |
| Deme, M | 1 |
| Stoll, HP | 1 |
| Cansino, AL | 1 |
| Muñoz-Marín, J | 1 |
| Guerrero, A | 2 |
| Sánchez de la Cuesta, F | 4 |
| Cañada, MJ | 1 |
| Muñoz Marín, J | 1 |
| Soares, PR | 1 |
| Hueb, WA | 1 |
| Lemos, PA | 1 |
| Lopes, N | 1 |
| Martinez, EE | 1 |
| Cesar, LA | 1 |
| Oliveira, SA | 1 |
| Ramires, JA | 1 |
| Kinduris, S | 1 |
| Vaisvila, T | 1 |
| Petronyte, J | 1 |
| Budrikis, A | 1 |
| Scheen, AJ | 1 |
| Legrand, D | 1 |
| Kraiem, S | 1 |
| Abassi, C | 1 |
| Annabi, N | 1 |
| Smaali, I | 1 |
| Issaa, I | 1 |
| Wali, M | 1 |
| Malou, M | 1 |
| Hannachi, S | 1 |
| Longo, S | 1 |
| Battikh, K | 1 |
| Slimane, ML | 1 |
| Jafarnejad, A | 1 |
| Bathaie, SZ | 1 |
| Nakhjavani, M | 1 |
| Hassan, MZ | 1 |
| Podolecka, E | 1 |
| Ciszewski, A | 1 |
| Kepka, C | 1 |
| Mazurkiewicz, Ł | 1 |
| Ruzyłło, W | 1 |
| Valone, J | 1 |
| Giugliano, D | 1 |
| Luyckx, AS | 1 |
| Lefebvre, PJ | 1 |
| Houben, AJ | 1 |
| Nieuwenhuijzen Kruseman, AC | 1 |
| Bouhouch, E | 1 |
| Slaaf, DW | 1 |
| Schaper, NC | 1 |
| Ferris, AM | 1 |
| Reece, EA | 1 |
| De Cosmo, S | 1 |
| Earle, K | 1 |
| Morocutti, A | 1 |
| Walker, J | 1 |
| Ruggenenti, P | 1 |
| Remuzzi, G | 1 |
| Viberti, GC | 1 |
| Homberg, M | 1 |
| Tschöpe, D | 1 |
| Greber, H | 1 |
| Hackländer, T | 1 |
| Schwippert, B | 1 |
| Gries, FA | 1 |
| Mödder, U | 1 |
| Braun, CI | 1 |
| Benson, WE | 1 |
| Remaley, NA | 1 |
| Chew, EY | 2 |
| Feke, GT | 1 |
| Yoshida, A | 1 |
| Ogasawara, H | 1 |
| Konno, S | 1 |
| Goger, DG | 1 |
| Buzney, SM | 1 |
| McMeel, JW | 1 |
| Franconi, F | 1 |
| Miceli, M | 1 |
| Fazzini, A | 1 |
| Seghieri, G | 1 |
| Caputo, S | 1 |
| DiLeo, MA | 1 |
| Lepore, D | 1 |
| Young, B | 1 |
| Moore, WS | 1 |
| Robertson, JT | 1 |
| Toole, JF | 1 |
| Ernst, CB | 1 |
| Cohen, SN | 1 |
| Broderick, JP | 1 |
| Dempsey, RJ | 1 |
| Hosking, JD | 1 |
| Ferris, F | 1 |
| Husstedt, IW | 1 |
| Grotemeyer, KH | 1 |
| Evers, S | 1 |
| Staschewski, F | 1 |
| Wertelewski, R | 1 |
| Simpfendorfer, C | 1 |
| Kottke-Marchant, K | 1 |
| Lowrie, M | 1 |
| Anders, RJ | 1 |
| Burns, DM | 1 |
| Miller, DP | 1 |
| Cove, CS | 1 |
| DeFranco, AC | 1 |
| Ellis, SG | 1 |
| Moliterno, DJ | 1 |
| Raymond, RE | 1 |
| Sutton, JM | 1 |
| Topol, EJ | 1 |
| Colwell, JA | 1 |
| Adamec, M | 1 |
| Saudek, F | 1 |
| Davis, MD | 1 |
| Fisher, MR | 1 |
| Gangnon, RE | 1 |
| Barton, F | 1 |
| Aiello, LM | 1 |
| Knatterud, GL | 1 |
| Caritis, S | 2 |
| Sibai, B | 1 |
| Hauth, J | 2 |
| Lindheimer, MD | 1 |
| Klebanoff, M | 2 |
| Thom, E | 1 |
| VanDorsten, P | 1 |
| Landon, M | 2 |
| Paul, R | 2 |
| Miodovnik, M | 2 |
| Meis, P | 2 |
| Thurnau, G | 2 |
| Rai, R | 1 |
| Regan, L | 1 |
| Moss, SE | 1 |
| Klein, BE | 1 |
| Wood, DM | 1 |
| Plehwe, WE | 1 |
| Colman, PG | 1 |
| Rajkumar, V | 1 |
| Ragatzki, P | 1 |
| Sima, A | 1 |
| Levy, J | 1 |
| Sibai, BM | 1 |
| Lindheimer, M | 1 |
| VanDorsten, JP | 1 |
| MacPherson, C | 1 |
| Dombrowski, M | 1 |
| Roberts, J | 1 |
| McNellis, D | 1 |
| Skyrme-Jones, RA | 2 |
| Meredith, IT | 2 |
| O'Brien, RC | 1 |
| Hansen, HP | 1 |
| Gaede, PH | 1 |
| Jensen, BR | 1 |
| Parving, HH | 1 |
| Baron, BW | 1 |
| Martin, MS | 1 |
| Sucharetza, BS | 1 |
| Jeon, H | 1 |
| Baron, JM | 1 |
| Teĭblium, MM | 1 |
| Waitzman, MB | 1 |
| Zannino, L | 1 |
| Salvadori, G | 1 |
| Eldor, A | 1 |
| Diaz, EG | 1 |
| Naparstek, E | 1 |
| Manske, CL | 1 |
| Wang, Y | 1 |
| Rector, T | 1 |
| Wilson, RF | 1 |
| White, CW | 1 |
| Ghiselli, A | 1 |
| Laurenti, O | 1 |
| De Mattia, G | 1 |
| Maiani, G | 1 |
| Ferro-Luzzi, A | 1 |
| Mori, TA | 1 |
| Vandongen, R | 1 |
| Douglas, AJ | 1 |
| McCulloch, RK | 1 |
| Burke, V | 1 |
| Patrassi, GM | 1 |
| Martinelli, S | 1 |
| Picchinenna, A | 1 |
| Girolami, A | 1 |
| Hopper, AH | 2 |
| Tindall, H | 2 |
| Davies, JA | 2 |
| Ehrich, JH | 1 |
| Wurster, U | 1 |
| Lütge, M | 1 |
| Doehring, E | 1 |
| Oemar, B | 1 |
| Pavia, J | 1 |
| Garcia-Arnes, J | 1 |
| Urquhart, S | 1 |
| Aguilar Muñoz, A | 1 |
| de la Cruz Cortés, JP | 1 |
| Martos Crespo, F | 1 |
| García Arnés, J | 1 |
| de Pablo Molina, J | 1 |
| DiMinno, G | 1 |
| Silver, MJ | 1 |
| Cerbone, AM | 1 |
| Riccardi, G | 1 |
| Rivellese, A | 1 |
| Mancini, M | 1 |
| Jones, DB | 1 |
| Haitas, B | 1 |
| Carter, RD | 1 |
| Bown, E | 1 |
| Mann, JI | 1 |
| Amado, JA | 1 |
| Suárez, M | 1 |
| Richard, C | 1 |
| Sedano, MC | 1 |
| Kaye, R | 1 |
| Athreya, BH | 1 |
| Kunzman, EE | 1 |
| Baker, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Impact of Aspirin Dose Modification on the Innate Immune Response - Will Lower Dose Aspirin Therapy Reduce the Response to Endotoxin[NCT03869268] | Phase 4 | 72 participants (Actual) | Interventional | 2019-04-24 | Completed | ||
| Effects of Low and High Doses of Aspirin Treatment on Fibrin Network Formation in Patients With Type 1 Diabetes and Possible Influence of the Glycemic Control.[NCT01397513] | Phase 4 | 48 participants (Actual) | Interventional | 2006-03-31 | Completed | ||
| Testing the Effectiveness of Different Messaging Approaches to Increase Doctor Visits to Confirm or Exclude a Diagnosis of Prediabetes or Diabetes Amongst Individuals With Risk Factors for Diabetes: A Randomised, Controlled Trial[NCT05755555] | 5,000 participants (Actual) | Interventional | 2022-08-04 | Active, not recruiting | |||
| Prospective, Single-Arm, Multi-Centre, Observational Registry to Further Validate Safety and Efficacy of the Nobori DES in Real-World Patients[NCT01261273] | 18,000 participants (Actual) | Observational | 2010-08-25 | Completed | |||
| BIOTRONIK-Safety and Clinical PerFormance of the Drug ELuting Orsiro Stent in the Treatment of Subjects With de Novo Coronary Artery Lesions-VI[NCT02870985] | Phase 3 | 440 participants (Anticipated) | Interventional | 2015-07-31 | Recruiting | ||
| Aqueous Biomarker Levels in Diabetic Retinopathy and Diabetic Macular Edema[NCT05333055] | 150 participants (Anticipated) | Observational | 2022-04-11 | Not yet recruiting | |||
| [NCT00000151] | Phase 3 | 0 participants | Interventional | 1979-12-31 | Completed | ||
| Long-Term Efficacy and Safety of Intravitreal Aflibercept Injections for the Treatment of Diabetic Retinopathy for Subjects Who Completed the 2-Year PANORAMA Trial[NCT04708145] | Phase 4 | 150 participants (Anticipated) | Interventional | 2021-06-01 | Active, not recruiting | ||
| Intravitreal Aflibercept for Retinal Non-Perfusion in Proliferative Diabetic Retinopathy[NCT02863354] | Phase 2 | 43 participants (Actual) | Interventional | 2016-08-31 | Completed | ||
| Intravitreal Aflibercept as Indicated by Real-Time Objective Imaging to Achieve Diabetic Retinopathy Improvement[NCT03531294] | Phase 2 | 40 participants (Actual) | Interventional | 2018-05-23 | Completed | ||
| Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial[NCT04855513] | 414 participants (Anticipated) | Interventional | 2022-03-24 | Not yet recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Change in area of retinal capillary non-perfusion outside of the macula from baseline to week 52 and week 100. (NCT02863354)
Timeframe: 52 weeks and 100 weeks
| Intervention | mm^2 (Mean) | |
|---|---|---|
| Week 52 | Week 100 | |
| Q12WKS | 240.472 | 387.204 |
| Q4WKS | 182.467 | 342.651 |
Change in area of retinal capillary non-perfusion within the macula compared to baseline, as assessed by ultrawide-field fluorescein angiogram from baseline to week 52 and week 100. (NCT02863354)
Timeframe: 52 weeks and 100 weeks
| Intervention | mm^2 (Mean) | |
|---|---|---|
| Week 52 | Week 100 | |
| Q12WKS | 0.217 | 0.940 |
| Q4WKS | 0.048 | 2.627 |
Change in area of total retinal capillary non-perfusion, as assessed by the central reading center, at week 52 and week 100 compared to baseline. (NCT02863354)
Timeframe: 52 weeks and 100 weeks
| Intervention | mm^2 (Mean) | |
|---|---|---|
| Week 52 | Week 100 | |
| Q12WKS | 66.752 | 245.694 |
| Q4WKS | -11.994 | 141.317 |
Mean change in Early Treatment of Diabetic Retinopathy Study Best Corrected Visual Acuity (ETDRS-BCVA) from baseline to week 52 and week 100. (NCT02863354)
Timeframe: 52 weeks and 100 weeks
| Intervention | ETDRS letters (Mean) | |
|---|---|---|
| Week 52 | Week 100 | |
| Q12WKS | 4.53 | 8.88 |
| Q4WKS | 4.26 | 4.06 |
Changes in self reported visual function utilizing the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) from baseline to week 52 and week 100. The NEI VFQ is a validated measure of patient-reported visual function measured on a scale from 0 (worst function) to 100 (best function). (NCT02863354)
Timeframe: 52 weeks and 100 weeks
| Intervention | units on a scale (Mean) | |
|---|---|---|
| Week 52 | Week 100 | |
| Q12WKS | 2.23 | 8.82 |
| Q4WKS | 6.27 | 8.91 |
Mean change in central subfield thickness (CST) from baseline to week 52 and week 100 (NCT02863354)
Timeframe: 52 weeks and 100 weeks
| Intervention | micrometers (Mean) | |
|---|---|---|
| Week 52 | Week 100 | |
| Q12WKS | -20.813 | -23.313 |
| Q4WKS | -32.947 | -35.059 |
• Assess the safety and tolerability of IAI for the treatment of proliferative diabetic retinopathy by evaluating the incidence and severity of ocular and systemic adverse events through week 52 and week 100. (NCT02863354)
Timeframe: 52 and 100 weeks
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Week 52 | Week 100 | |
| Q12WKS | 0 | 0 |
| Q4WKS | 0 | 0 |
Percentage of subjects treated with PRP or vitrectomy for progression of PDR from baseline to week 52 and week 100. (NCT02863354)
Timeframe: 52 Weeks and 100 Weeks
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Week 52 | Week 100 | |
| Q12WKS | 0 | 0 |
| Q4WKS | 0 | 0 |
Percentage of subjects, at week 52 and week 100, who develop center-involving diabetic macular edema who did not have center-involving diabetic macular edema at baseline (NCT02863354)
Timeframe: 52 Weeks and 100 Weeks
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Week 52 | Week 100 | |
| Q12WKS | 0 | 0 |
| Q4WKS | 0 | 0 |
Percentage of subjects who develop vitreous hemorrhage from baseline to week 52 and week 100. (NCT02863354)
Timeframe: 52 Weeks and 100 Weeks
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Week 52 | Week 100 | |
| Q12WKS | 1 | 1 |
| Q4WKS | 2 | 4 |
Percentage of subjects with increased neovascularization from baseline to week 52 and week 100. (NCT02863354)
Timeframe: 52 Weeks and 100 Weeks
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Week 52 | Week 100 | |
| Q12WKS | 0 | 0 |
| Q4WKS | 1 | 0 |
Percentage of subjects with neovascularization regression (reduced area of neovascularization) as measured by the central image reading center from baseline to week 52 and week 100. (NCT02863354)
Timeframe: 52 Weeks and 100 Weeks
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| Week 52 | Week 100 | |
| Q12WKS | 18 | 15 |
| Q4WKS | 17 | 17 |
17 reviews available for aspirin and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets.
Topics: Antihypertensive Agents; Aspirin; Blood Glucose; Blood Glucose Self-Monitoring; Diabetes Mellitus, T | 2023 |
Family History of Hypertension, Cardiovascular Disease, or Diabetes and Risk of Developing Preeclampsia: A Systematic Review.
Topics: Aspirin; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Female; Humans; Hypertension; Pre-Eclam | 2021 |
Aspirin in primary prevention for patients with diabetes: Still a matter of debate.
Topics: Aspirin; Blood Platelets; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathie | 2018 |
Diabetes and acute coronary syndromes.
Topics: Acute Coronary Syndrome; Anticoagulants; Aspirin; Blood Glucose; Clopidogrel; Diabetes Mellitus; Dia | 2009 |
Antiplatelet therapy in patients with diabetes mellitus.
Topics: Animals; Aspirin; Blood Platelets; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic An | 2012 |
Obstetric nephrology: pregnancy in women with diabetic nephropathy--the role of antihypertensive treatment.
Topics: Albuminuria; Antihypertensive Agents; Aspirin; Counseling; Diabetes Mellitus, Type 1; Diabetes Melli | 2012 |
Drugs for cardiovascular risk reduction in the diabetic patient.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Diabetes Mellitus, Type 1 | 2001 |
[Inflammation and diabetes].
Topics: Adiponectin; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Arte | 2004 |
[Cardiovascular protection and prevention in patients with cardiac conditions and diabetes].
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Blood Glucose; Cardi | 2005 |
Blood platelet abnormalities and pharmacological modulation of platelet reactivity in patients with diabetes mellitus.
Topics: Aspirin; Blood Platelets; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathie | 2005 |
[Screening and management of coronary artery disease in diabetic patients].
Topics: Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inh | 2006 |
Proliferative diabetic retinopathy and patient age: presentation, prognosis, and management.
Topics: Adolescent; Adult; Age Factors; Anticoagulants; Aspirin; Diabetes Mellitus, Type 1; Diabetic Retinop | 1984 |
Nutritional consequences of chronic maternal conditions during pregnancy and lactation: lupus and diabetes.
Topics: Adult; Aspirin; Autoimmune Diseases; Diabetes Mellitus, Type 1; Female; Humans; Lactation Disorders; | 1994 |
Antiphospholipid syndrome and pregnancy loss.
Topics: Abortion, Habitual; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antiphospholipid Syndro | 1998 |
Four patients with both thrombotic thrombocytopenic purpura and autoimmune thrombocytopenic purpura: the concept of a mixed immune thrombocytopenia syndrome and indications for plasma exchange.
Topics: Adult; Arthritis, Rheumatoid; Aspirin; Autoimmune Diseases; Blood Platelets; Combined Modality Thera | 2001 |
Proposed metabolic dysfunctions in diabetic microthromboses and microangiopathy.
Topics: Alprostadil; Aspirin; Blood Platelets; Calcimycin; Collagen; Cyclic AMP; Cyclic GMP; Diabetes Mellit | 1979 |
[Platelet aggregation inhibitors. Their possible use in pediatric pathology].
Topics: Age Factors; Anti-Inflammatory Agents; Aspirin; Child; Clofibrate; Dextrans; Diabetes Mellitus, Type | 1979 |
23 trials available for aspirin and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control.
Topics: Adolescent; Adult; Aspirin; Biomarkers; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 1 | 2021 |
The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.
Topics: Adult; Aged; Antioxidants; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic A | 2008 |
[Correction of the disturbed coagulation circadian rhythm in patients with type 1 diabetes mellitus treated by aspirin chronotherapy].
Topics: Administration, Oral; Adolescent; Adult; Aspirin; Blood Coagulation; Circadian Rhythm; Diabetes Mell | 2008 |
High-dose aspirin is required to influence plasma fibrin network structure in patients with type 1 diabetes.
Topics: Aspirin; Chromatography, High Pressure Liquid; Diabetes Mellitus, Type 1; Drug Administration Schedu | 2012 |
Aspirin sensitivity of platelet aggregation in diabetes mellitus.
Topics: Aspirin; Cardiotonic Agents; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Humans; M | 2005 |
Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the Medicine, Angioplasty, or Surgery Study (MASS II).
Topics: Adrenergic beta-Antagonists; Aged; Angioplasty, Balloon, Coronary; Angioplasty, Balloon, Laser-Assis | 2006 |
Peripheral macro- and microcirculation in short-term insulin-dependent diabetes mellitus: the role of prostaglandins in early haemodynamic changes.
Topics: Adult; Aspirin; Blood Circulation; Blood Glucose; Diabetes Mellitus, Type 1; Double-Blind Method; Fe | 1993 |
Glucose-induced changes in renal haemodynamics in proteinuric type 1 (insulin-dependent) diabetic patients: inhibition by acetylsalicilic acid infusion.
Topics: Adult; Analysis of Variance; Aspirin; Biopsy; Blood Proteins; Diabetes Mellitus, Type 1; Diabetic Ne | 1993 |
Accommodative amplitudes in the Early Treatment Diabetic Retinopathy Study.
Topics: Accommodation, Ocular; Adolescent; Adult; Age Factors; Aspirin; Diabetes Mellitus, Type 1; Diabetes | 1995 |
Retinal blood flow increases following short-term aspirin usage in type I diabetics with no or minimal retinopathy.
Topics: Adult; Aspirin; Blood Flow Velocity; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetic Retinop | 1996 |
An analysis of perioperative surgical mortality and morbidity in the asymptomatic carotid atherosclerosis study. ACAS Investigators. Asymptomatic Carotid Atherosclerosis Study.
Topics: Anesthesia; Arteriosclerosis; Aspirin; Carotid Stenosis; Cerebral Infarction; Combined Modality Ther | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
Early photocoagulation in patients with either type I or type II diabetes.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitu | 1996 |
First chronic platelet glycoprotein IIb/IIIa integrin blockade. A randomized, placebo-controlled pilot study of xemilofiban in unstable angina with percutaneous coronary interventions.
Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Benzamidines; Coronary Arter | 1997 |
Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report #18.
Topics: Adolescent; Adult; Aged; Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neu | 1998 |
Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Topics: Adult; Aspirin; Chronic Disease; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Humans; Hyp | 1998 |
Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Topics: Aspirin; Birth Weight; Blood Pressure; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; | 2000 |
Lack of impact of low-dose acetylsalicylic acid on kidney function in type 1 diabetic patients with microalbuminuria.
Topics: Adult; Albuminuria; Aspirin; Blood Pressure; Chromatography, High Pressure Liquid; Cross-Over Studie | 2000 |
[Effects of aspirin standard therapy and chronotherapy on circadian organization of hemocoagulation in patients with insulin-dependent diabetes mellitus].
Topics: Adolescent; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Coagulation; Chronotherap | 2002 |
Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure.
Topics: Adult; Angina, Unstable; Angioplasty, Balloon, Coronary; Aspirin; Calcium Channel Blockers; Coronary | 1992 |
Administration of aspirin-dipyridamole reduces proteinuria in diabetic nephropathy.
Topics: Adult; Aspirin; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Dipyridamole; Double-Blind Method | 1989 |
Effect of aspirin alone and aspirin plus dipyridamole in early diabetic retinopathy. A multicenter randomized controlled clinical trial. The DAMAD Study Group.
Topics: Adult; Aspirin; Blood Pressure; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellit | 1989 |
Reduction of exercise-induced albuminuria by aspirin-dipyridamole in patients with diabetes mellitus.
Topics: Adult; Albuminuria; Aspirin; Diabetes Mellitus, Type 1; Dipyridamole; Drug Therapy, Combination; Hum | 1987 |
[Effect of dipyridamole (225 mg/day) and acetylsalicylic acid (150 mg/day) on various platelet parameters in non-complicated diabetes mellitus].
Topics: Aspirin; Blood Platelets; Diabetes Mellitus, Type 1; Dipyridamole; Humans; Malondialdehyde; Platelet | 1986 |
58 other studies available for aspirin and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Long-term aspirin administration suppresses inflammation in diabetic cystopathy.
Topics: Animals; Aspirin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Inflammation; Male; Ra | 2023 |
Society for Maternal-Fetal Medicine Special Statement: Updated checklist for antepartum care of pregestational diabetes mellitus.
Topics: Aspirin; Checklist; Delivery, Obstetric; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Disea | 2020 |
Compression force sensing regulates integrin α
Topics: Adult; Animals; Aspirin; Blood Platelets; Clopidogrel; Diabetes Mellitus, Type 1; Female; Humans; Ma | 2018 |
Novel reno-protective mechanism of Aspirin involves H2AK119 monoubiquitination and Set7 in preventing type 1 diabetic nephropathy.
Topics: Animals; Aspirin; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Diabetic Nephropathies | 2018 |
The myth of autoimmunity.
Topics: Antibodies; Antigens; Aspirin; Autoimmune Diseases; Autoimmunity; Crohn Disease; Diabetes Mellitus, | 2018 |
ACOG Practice Bulletin No. 201 Summary: Pregestational Diabetes Mellitus.
Topics: Administration, Oral; Aspirin; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; | 2018 |
An Irish National Diabetes in Pregnancy Audit: aiming for best outcomes for women with diabetes.
Topics: Abortion, Spontaneous; Adult; Aspirin; Cesarean Section; Clinical Audit; Delivery of Health Care; De | 2020 |
Sex-specific-differences in cardiometabolic risk in type 1 diabetes: a cross-sectional study.
Topics: Adult; Aspirin; Blood Pressure; Cardiovascular Diseases; Cross-Sectional Studies; Diabetes Complicat | 2013 |
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes.
Topics: Adult; Albuminuria; Aspirin; Blood Glucose; Cross-Sectional Studies; Cyclooxygenase 1; Diabetes Mell | 2016 |
Platelet Dysfunction in Type 1 Diabetes: Stressing the Thromboxanes.
Topics: Aspirin; Diabetes Mellitus, Type 1; Epoprostenol; Female; Humans; Male; Platelet Activation; Platele | 2016 |
Value of Coronary Computed Tomography Angiography in Tailoring Aspirin Therapy for Primary Prevention of Atherosclerotic Events in Patients at High Risk With Diabetes Mellitus.
Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Body Mass Index; Coronary Angiography; Coron | 2016 |
Microparticle Shedding by Erythrocytes, Monocytes and Vascular Smooth Muscular Cells Is Reduced by Aspirin in Diabetic Patients.
Topics: Adult; Aged; Aspirin; Blood Platelets; Cardiovascular Diseases; Cell-Derived Microparticles; Diabete | 2016 |
COX-1 sensitivity and thromboxane A2 production in type 1 and type 2 diabetic patients under chronic aspirin treatment.
Topics: Adult; Aged; Aspirin; Blood Platelets; C-Reactive Protein; Case-Control Studies; Cyclooxygenase 1; D | 2009 |
Aspirin: not currently for primary prevention in diabetes.
Topics: Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Humans; Off-La | 2009 |
Effect of virgin olive oil plus acetylsalicylic acid on brain slices damage after hypoxia-reoxygenation in rats with type 1-like diabetes mellitus.
Topics: Animals; Aspirin; Brain; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Hypoxia, Brain; | 2010 |
Influence of pharmacist intervention on prescribing of angiotensin-converting-enzyme inhibitors, angiotensin II-receptor blockers, and aspirin for diabetic patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Con | 2010 |
Combination of aspirin with telmisartan suppresses the augmented TGFbeta/smad signaling during the development of streptozotocin-induced type I diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; | 2010 |
Clinico-pathologic conference: case 6.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antihypertensive Agents; Aspirin; Carcinoma, Squamous Cell; | 2009 |
Unclassified pleomorphic and spindle cell pulmonary neoplasm with brain metastases after prasugrel.
Topics: Aged; Aspirin; Brain Neoplasms; Carcinoma; Clinical Trials, Phase III as Topic; Clopidogrel; Colonic | 2013 |
Under-prescribing of cardiovascular therapies for diabetes in primary care.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibit | 2003 |
Prevention of primary non-function of islet xenografts in autoimmune diabetic NOD mice by anti-inflammatory agents.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase Inhibitors; Diabetes Melli | 2003 |
Retinopathy in diabetes.
Topics: Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Humans; Laser C | 2004 |
Does cardiovascular therapy affect the onset and recurrence of preretinal and vitreous haemorrhage in diabetic eye disease?
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Aspirin; Cardiovascular Agents; Cardiovascula | 2004 |
[Risk intervention in persons with diabetes mellitus in general practice].
Topics: Adult; Aged; Anticholesteremic Agents; Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Di | 2004 |
Comparative blood studies in Jamaican diabetic patients.
Topics: Aspirin; Blood Sedimentation; Blood Viscosity; Comorbidity; Diabetes Mellitus, Type 1; Erythrocyte A | 2004 |
Management of ischaemic heart disease in women of child-bearing age.
Topics: Adult; Aspirin; Diabetes Mellitus, Type 1; Female; Fibrinolytic Agents; Humans; Hypoglycemic Agents; | 2004 |
Cardiovascular disease morbidity and mortality in patients with type 1 diabetes mellitus : management strategies.
Topics: Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Humans; Hypogl | 2005 |
Treatment disparities in the care of patients with and without diabetes presenting with non-ST-segment elevation acute coronary syndromes.
Topics: Acute Disease; Adrenergic beta-Antagonists; Adult; Aspirin; Cardiac Catheterization; Clopidogrel; Co | 2006 |
Comparison of aspirin resistance in type 1 versus type 2 diabetes mellitus.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cardiovascular Diseases; Cholesterol, HDL; Diabetes Mellitu | 2006 |
Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Clopidogrel; Comorbidity; Coronary Di | 2006 |
Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Clopidogrel; Comorbidity; Coronary Di | 2006 |
Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Clopidogrel; Comorbidity; Coronary Di | 2006 |
Safety of coronary sirolimus-eluting stents in daily clinical practice: one-year follow-up of the e-Cypher registry.
Topics: Aged; Angioplasty, Balloon, Coronary; Aspirin; Cause of Death; Clopidogrel; Comorbidity; Coronary Di | 2006 |
Effects of aspirin plus alpha-tocopherol on brain slices damage after hypoxia-reoxygenation in rats with type 1-like diabetes mellitus.
Topics: alpha-Tocopherol; Animals; Antioxidants; Aspirin; Brain Ischemia; Cells, Cultured; Diabetes Mellitus | 2006 |
Antioxidant and antiplatelet effects of the alpha-tocopherol-aspirin combination in type 1-like diabetic rats.
Topics: alpha-Tocopherol; Animals; Antioxidants; Aspirin; Diabetes Mellitus, Experimental; Diabetes Mellitus | 2006 |
[Bleeding after cardiac surgery: risk factors, frequency, and outcomes].
Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Cardiac Surgical Procedures; Diabetes Mellitus, | 2006 |
Aspirin and clopidogrel resistance in patients with diabetes mellitus.
Topics: Aspirin; Clopidogrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; D | 2006 |
Investigation of the mechanisms involved in the high-dose and long-term acetyl salicylic acid therapy of type I diabetic rats.
Topics: Animals; Aspirin; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Diabetes Mellitus, Ty | 2008 |
[Acetylsalicylic acid hypersensitivity in a patient with coronary artery disease and insulin-dependent diabetes mellitus].
Topics: Angioplasty, Balloon, Coronary; Aspirin; Coronary Angiography; Coronary Artery Disease; Desensitizat | 2008 |
Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics.
Topics: Adolescent; Adult; Alanine; Arginine; Aspirin; Blood Glucose; C-Peptide; Diabetes Mellitus, Type 1; | 1980 |
[Optic neuropathy in type-1 diabetes and acetylsalicylic acid-refractory thrombocyte activation].
Topics: Adult; Aspirin; Chronic Disease; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Neuropa | 1993 |
Taurine and diabetes. Humans and experimental models.
Topics: Animals; Arachidonic Acid; Aspirin; Blood Platelets; Diabetes Mellitus, Experimental; Diabetes Melli | 1996 |
Progression of distal symmetric polyneuropathy during diabetes mellitus: clinical, neurophysiological, haemorheological changes and self-rating scales of patients.
Topics: Adolescent; Adult; Aged; Aspirin; Blood Glucose; Blood Viscosity; Diabetes Mellitus, Type 1; Diabete | 1997 |
Aspirin therapy in diabetes mellitus.
Topics: Aspirin; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Gastrointestin | 1997 |
Our experience with pancreatic graft extraperitoneal placement.
Topics: Adult; Anticoagulants; Aspirin; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Com | 1997 |
The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin Epidemiologic Study of Diabetic Retinopathy.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Aged; Amputation, Surgical; Aspirin; Blood Pressure; D | 1999 |
Aspirin usage in a large teaching hospital diabetes clinic setting.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Australia; Diabetes Mellitus, Type 1; Diabetes Mellitus, Ty | 1999 |
Enhanced platelet aggregation, high homocysteine level, and microvascular disease in diabetic muscle infarctions: implications for therapy.
Topics: Adult; Aspirin; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Female; Folic Acid; Hematinics; Ho | 1999 |
Aspirin does not improve endothelial vasodilator function in Type 1 diabetes mellitus.
Topics: Acetylcholine; Adult; Aspirin; Blood Glucose; Brachial Artery; Diabetes Mellitus, Type 1; Endotheliu | 2000 |
Vasodilator prostanoids, but not nitric oxide, may account for skeletal muscle hyperaemia in Type I diabetes mellitus.
Topics: Adult; Area Under Curve; Aspirin; Case-Control Studies; Cyclooxygenase Inhibitors; Diabetes Mellitus | 2000 |
Treatment of diabetic necrobiosis with aspirin and dipyridamole.
Topics: Adult; Aspirin; Diabetes Mellitus, Type 1; Dipyridamole; Female; Humans; Necrobiosis Lipoidica | 1978 |
Treatment of diabetic necrobiosis with aspirin or dipyridamole.
Topics: Adolescent; Adult; Animals; Aspirin; Diabetes Complications; Diabetes Mellitus, Type 1; Dipyridamole | 1978 |
Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients.
Topics: Adult; Aspirin; Diabetes Mellitus, Type 1; Female; Gentisates; Humans; Hydroxybenzoates; Hydroxylati | 1992 |
Differential effect of aspirin on platelet aggregation in IDDM.
Topics: Adult; Aspirin; Blood Pressure; Cholesterol; Collagen; Diabetes Mellitus, Type 1; Fatty Acids, Omega | 1992 |
Contact phase of coagulation in diabetes mellitus after aspirin administration.
Topics: Aspirin; Blood Coagulation; Blood Platelets; Diabetes Mellitus, Type 1; Factor XI; Factor XII; Femal | 1985 |
[Enzymuria and kidney diseases in childhood].
Topics: Acetylglucosaminidase; Adolescent; Aminopeptidases; Anti-Bacterial Agents; Aspirin; CD13 Antigens; C | 1986 |
Effects of triflusal and acetylsalicylic acid on platelet aggregation in whole blood of diabetic patients.
Topics: Adult; Aspirin; beta-Thromboglobulin; Diabetes Mellitus, Type 1; Humans; Male; Platelet Aggregation; | 1988 |
Platelet fibrinogen binding in diabetes mellitus. Differences between binding to platelets from nonretinopathic and retinopathic diabetic patients.
Topics: Adolescent; Adult; Apyrase; Aspirin; Blood Platelets; Diabetes Mellitus, Type 1; Diabetic Retinopath | 1986 |
Prostaglandin synthesis inhibition reduces platelet aggregation in diabetes mellitus.
Topics: Aspirin; Diabetes Mellitus, Type 1; Dipyridamole; Humans; Platelet Aggregation; Prostaglandins | 1985 |
Influence of acetylsalicylic acid on bleeding time and serum thromboxane B2 in diabetes mellitus type I.
Topics: Adolescent; Adult; Aspirin; Bleeding Time; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Female; | 1985 |
Antipyretics in patients with juvenile diabetes mellitus. Comparison of salicylate and a salicylate substitute (experimental preparation PAJ-102).
Topics: Acetaminophen; Adolescent; Aspirin; Blood Glucose; Child; Diabetes Mellitus, Type 1; Drug Administra | 1966 |